Vitamin D Evidence | Supplement Intelligence

Evidence posture

Established nutrient role in calcium/bone physiology and deficiency prevention; many broader supplementation claims remain unproven.

What the evidence supports

Vitamin D is required for calcium absorption and normal bone mineralization. NIH ODS notes that evidence for many non-bone outcomes is inadequate or contradictory, especially in vitamin-D-replete populations.

Studied context

Clinical interpretation depends on baseline vitamin D status and dose. Serum 25-hydroxyvitamin D is the usual status marker.

Safety context

Excess supplemental vitamin D can cause hypercalcemia and other serious toxicity. The adult tolerable upper intake level is generally 4,000 IU/day unless medically supervised.

Product directness

Several current products list vitamin D3, but their manufacturer pages do not consistently provide dose amounts. Broad immune, metabolic, or performance claims should not be inferred solely from inclusion of vitamin D.

Products that list this ingredient/category

Primary and authoritative sources

Review-level evidence highlights

Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis (Meta-analysis of randomized controlled trials; PMID 35504603)

Population/scope: Adults across 32 randomized studies

Evidence scope: Fracture and fall outcomes

Finding: Benefits were not uniform across dosing regimens; some daily-dose subgroups showed lower fracture/fall risk while other dosing patterns did not.

Limitations: Effects depend on dose, dosing interval, calcium co-administration, baseline status, age, and population; subgroup findings should not be treated as universal.

Directness: Relevant human evidence · verified 2026-10-02

Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis (Systematic review and meta-analysis of randomized controlled trials; PMID 37120684)

Population/scope: Adults in 15 randomized trials of intermittent or single high-dose vitamin D

Evidence scope: Falls and fractures

Finding: Intermittent or single high-dose vitamin D did not prevent falls or fractures and may increase fall risk.

Limitations: Applies to intermittent/high-dose regimens and should not be generalized to routine daily replacement in deficient individuals.

Directness: Relevant human evidence · verified 2026-10-02

Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.